Targeted Medical Pharma, Inc. (TRGM)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Nov 12, 2025
Targeted Medical Pharma Statistics
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
TRGM has 29.47 million shares outstanding.
| Current Share Class | 29.47M |
| Shares Outstanding | 29.47M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.85% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.00 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.06
| Current Ratio | 0.06 |
| Quick Ratio | 0.04 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.61 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -47.96% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 15.43% |
| Weighted Average Cost of Capital (WACC) | 17.51% |
| Revenue Per Employee | 175,365 |
| Profits Per Employee | -101,460 |
| Employee Count | 30 |
| Asset Turnover | 2.14 |
| Inventory Turnover | 19.11 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | -0.15 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | 2,117 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.28 |
Income Statement
In the last 12 months, TRGM had revenue of 5.26 million and -3.04 million in losses. Loss per share was -0.11.
| Revenue | 5.26M |
| Gross Profit | 3.17M |
| Operating Income | -1.89M |
| Pretax Income | -3.07M |
| Net Income | -3.04M |
| EBITDA | -1.66M |
| EBIT | -1.89M |
| Loss Per Share | -0.11 |
Balance Sheet
The company has 82,643 in cash and 5.29 million in debt, with a net cash position of -5.21 million or -0.18 per share.
| Cash & Cash Equivalents | 82,643 |
| Total Debt | 5.29M |
| Net Cash | -5.21M |
| Net Cash Per Share | -0.18 |
| Equity (Book Value) | -12.92M |
| Book Value Per Share | -0.47 |
| Working Capital | -13.84M |
Cash Flow
| Operating Cash Flow | -1.28M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 60.17%, with operating and profit margins of -35.93% and -57.86%.
| Gross Margin | 60.17% |
| Operating Margin | -35.93% |
| Pretax Margin | -58.30% |
| Profit Margin | -57.86% |
| EBITDA Margin | -31.55% |
| EBIT Margin | -35.93% |
| FCF Margin | n/a |
Dividends & Yields
TRGM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.16% |
| Shareholder Yield | -3.16% |
| Earnings Yield | -10,495,896.55% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TRGM has an Altman Z-Score of -24.41 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -24.41 |
| Piotroski F-Score | 3 |